4-102593584-T-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003998.4(NFKB1):​c.1210+16T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.338 in 1,600,628 control chromosomes in the GnomAD database, including 93,617 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.32 ( 8295 hom., cov: 32)
Exomes 𝑓: 0.34 ( 85322 hom. )

Consequence

NFKB1
NM_003998.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.957
Variant links:
Genes affected
NFKB1 (HGNC:7794): (nuclear factor kappa B subunit 1) This gene encodes a 105 kD protein which can undergo cotranslational processing by the 26S proteasome to produce a 50 kD protein. The 105 kD protein is a Rel protein-specific transcription inhibitor and the 50 kD protein is a DNA binding subunit of the NF-kappa-B (NFKB) protein complex. NFKB is a transcription regulator that is activated by various intra- and extra-cellular stimuli such as cytokines, oxidant-free radicals, ultraviolet irradiation, and bacterial or viral products. Activated NFKB translocates into the nucleus and stimulates the expression of genes involved in a wide variety of biological functions. Inappropriate activation of NFKB has been associated with a number of inflammatory diseases while persistent inhibition of NFKB leads to inappropriate immune cell development or delayed cell growth. NFKB is a critical regulator of the immediate-early response to viral infection. Alternative splicing results in multiple transcript variants encoding different isoforms, at least one of which is proteolytically processed. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant 4-102593584-T-C is Benign according to our data. Variant chr4-102593584-T-C is described in ClinVar as [Benign]. Clinvar id is 1168266.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-102593584-T-C is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.412 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
NFKB1NM_003998.4 linkuse as main transcriptc.1210+16T>C intron_variant ENST00000226574.9

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
NFKB1ENST00000226574.9 linkuse as main transcriptc.1210+16T>C intron_variant 1 NM_003998.4 P4P19838-2

Frequencies

GnomAD3 genomes
AF:
0.323
AC:
49083
AN:
151876
Hom.:
8281
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.256
Gnomad AMI
AF:
0.301
Gnomad AMR
AF:
0.414
Gnomad ASJ
AF:
0.303
Gnomad EAS
AF:
0.426
Gnomad SAS
AF:
0.282
Gnomad FIN
AF:
0.384
Gnomad MID
AF:
0.241
Gnomad NFE
AF:
0.332
Gnomad OTH
AF:
0.305
GnomAD3 exomes
AF:
0.358
AC:
87122
AN:
243112
Hom.:
16735
AF XY:
0.349
AC XY:
45861
AN XY:
131590
show subpopulations
Gnomad AFR exome
AF:
0.256
Gnomad AMR exome
AF:
0.541
Gnomad ASJ exome
AF:
0.306
Gnomad EAS exome
AF:
0.443
Gnomad SAS exome
AF:
0.276
Gnomad FIN exome
AF:
0.386
Gnomad NFE exome
AF:
0.328
Gnomad OTH exome
AF:
0.341
GnomAD4 exome
AF:
0.339
AC:
491244
AN:
1448634
Hom.:
85322
Cov.:
34
AF XY:
0.336
AC XY:
242470
AN XY:
721018
show subpopulations
Gnomad4 AFR exome
AF:
0.245
Gnomad4 AMR exome
AF:
0.524
Gnomad4 ASJ exome
AF:
0.306
Gnomad4 EAS exome
AF:
0.380
Gnomad4 SAS exome
AF:
0.279
Gnomad4 FIN exome
AF:
0.375
Gnomad4 NFE exome
AF:
0.337
Gnomad4 OTH exome
AF:
0.340
GnomAD4 genome
AF:
0.323
AC:
49121
AN:
151994
Hom.:
8295
Cov.:
32
AF XY:
0.328
AC XY:
24344
AN XY:
74274
show subpopulations
Gnomad4 AFR
AF:
0.256
Gnomad4 AMR
AF:
0.415
Gnomad4 ASJ
AF:
0.303
Gnomad4 EAS
AF:
0.427
Gnomad4 SAS
AF:
0.280
Gnomad4 FIN
AF:
0.384
Gnomad4 NFE
AF:
0.332
Gnomad4 OTH
AF:
0.301
Alfa
AF:
0.279
Hom.:
1545
Bravo
AF:
0.325
Asia WGS
AF:
0.370
AC:
1286
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitterclinical testingGeneDxSep 11, 2018- -
Benign, criteria provided, single submitterclinical testingInvitaeFeb 01, 2024- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanNov 12, 2023This variant is classified as Benign based on local population frequency. This variant was detected in 61% of patients studied by a panel of primary immunodeficiencies. Number of patients: 59. Only high quality variants are reported. -
Immunodeficiency, common variable, 12 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabSep 05, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.20
DANN
Benign
0.46
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs4648050; hg19: chr4-103514741; COSMIC: COSV56957061; COSMIC: COSV56957061; API